Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
72.1M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
7.05M
-
Shares change
-
-774K
-
Total reported value, excl. options
-
$49.8M
-
Value change
-
-$9.28M
-
Number of buys
-
35
-
Number of sells
-
-17
-
Price
-
$7.07
Significant Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q1 2018
58 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q1 2018.
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.05M shares
of 72.1M outstanding shares and own 9.78% of the company stock.
Largest 10 shareholders include FMR LLC (1.39M shares), BlackRock Inc. (1.36M shares), JENNISON ASSOCIATES LLC (651K shares), Tekla Capital Management LLC (536K shares), OppenheimerFunds, Inc. (424K shares), VANGUARD GROUP INC (401K shares), PRICE T ROWE ASSOCIATES INC /MD/ (300K shares), DEUTSCHE BANK AG\ (296K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (284K shares), and BAKER BROS. ADVISORS LP (248K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.